New TB drug trial shows breakthrough potential
Sorfequiline, a new antibiotic, demonstrates stronger action against tuberculosis in recent trials, potentially revolutionising treatment for the disease that killed 1.23 million last year.
Sorfequiline, a new antibiotic, demonstrates stronger action against tuberculosis in recent trials, potentially revolutionising treatment for the disease that killed 1.23 million last year.